HV
Hannah Valantine
DELAYED 1 MONTH
Director
BridgeBio Pharma, Inc.
PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
Filings
3
Companies
2
Latest
Jun 3, 2026
Transactions
Signal
Ticker / Company
Insider
Transaction
Value
Filed
—
BridgeBio Pharma, Inc.
Hannah Valantine
Director
Option Exercise
$237.2K
8,671 sh
Mar 12 8:15 PM
Mar 10, 2026
61
BBIO77% OUT
BridgeBio Pharma, Inc.
Hannah Valantine
Director
Sale
$1.7M
25,484 sh
Mar 3 9:17 PM
Feb 27, 2026
—
BridgeBio Pharma, Inc.
Hannah Valantine
Director
Option Exercise
$1.2M
25,484 sh
Mar 3 9:17 PM
Feb 27, 2026